Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 4 178 345 | déclaré | 29 déc. 2025 | tx 218+10 181 954−7 022 461 |
| THERMOGENESIS CORP | 122 750 | déclaré | 01 juil. 2014 | tx 26+327 000−134 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 29 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 26 334 | — | |
| 29 déc. 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 6 786 | — | |
| 29 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 26 334 | 0.00 USD | deriv |
| 08 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 3 534 | — | |
| 08 déc. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 3 534 | 0.00 USD | deriv |
| 01 déc. 2025 | GIFT | CATALYST PHARMACEUTICALS, INC. | 45 000 | 0.00 USD | |
| 01 déc. 2025 | GIFT | CATALYST PHARMACEUTICALS, INC. | 45 000 | 0.00 USD | |
| 01 déc. 2025 | GIFT | CATALYST PHARMACEUTICALS, INC. | 45 000 | 0.00 USD | |
| 21 nov. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 775 | — | |
| 20 nov. 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 34 921 | 0.00 USD | deriv |
| 20 nov. 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 10 540 | 0.00 USD | deriv |
| 21 nov. 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1 775 | 0.00 USD | deriv |
| 09 juin 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 171 748 | 26.11 USD | |
| 06 juin 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 28 252 | 25.95 USD | |
| 09 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 3 533 | — | |
| 09 déc. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 3 533 | 0.00 USD | deriv |
| 21 nov. 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 43 591 | 0.00 USD | deriv |
| 21 nov. 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 5 327 | 0.00 USD | deriv |
| 19 nov. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 98 345 | 3.54 USD | |
| 19 nov. 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 98 345 | 21.19 USD | |
| 20 nov. 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 72 500 | 21.29 USD | |
| 20 nov. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 72 500 | 3.54 USD | |
| 19 nov. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 98 345 | 0.00 USD | deriv |
| 20 nov. 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 72 500 | 0.00 USD | deriv |
| 13 nov. 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 92 500 | 22.98 USD |
2 achats déclarés après au moins 12 mois de silence — dernière occurrence le 05 sept. 2017.